HQ: San Francsico, CA
Leadership: Celine Halioua
Website: loyal.com
Opportunity: Increase the quality of life for dogs as they age and experience a decline in metabolic fitness.
Vision: Loyal is the first company to develop a suite of lifespan-extending drugs for dogs, helping them live longer, healthier lives by improving metabolic health and slowing aging. The FDA has granted conditional approval for LOY-002, acknowledging the pill’s potential to extend the lifespan of senior dogs.
Status: Active
